Cervical cancer is the fourth most common malignancy in females worldwide, and a leading
cause of death in the United Kingdom (UK). The human papillomavirus (HPV) is the …

Objective To explore the efficacy of human papillomavirus (HPV) vaccination on the risk of
HPV infection and recurrent diseases related to HPV infection in individuals undergoing …

The objective of this work is to assess the 5-year outcomes of patients undergoing
conization for high-grade cervical lesions that simultaneously present as risk factors in the …

In 2006 HPV vaccination was licensed for primary prevention of HPV related disease in
young females.[1]. Only a few years after, immunological and clinical studies offered new …

Objective To measure the effectiveness of the quadrivalent human papillomavirus (HPV)
vaccine against cervical abnormalities four years after implementation of a nationally funded …

An estimated 5% of human cancers are caused by human papillomavirus (HPV) infections,
and most of these cancers are of the cervix. Two prophylactic HPV vaccines that target the …

Objectives This study was conducted to determine whether vaccination with the quadrivalent
human papillomavirus (HPV) vaccine after loop electrosurgical excision procedure (LEEP) …

Objective: The aim of this meta-analysis was to discuss evidence supporting the efficacy of
adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical …

OBJECTIVE: To perform a systematic review and meta-analysis evaluating the efficacy of
adjuvant human papillomavirus (HPV) vaccination in preventing recurrent cervical …

Background Adults living with human immunodeficiency virus (HIV) are at increased risk for
anal and oropharyngeal cancer caused by human papillomavirus (HPV). The efficacy of …